Idiopathic Pulmonary Fibrosis: all 565 studies
Page 4 of 6. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Study of TTI-101 in Participants With Idiopathic Pulmonary FibrosisCompletedNCT05671835Phase 2
- Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001CompletedNCT05657184Phase 1
- Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary FibrosisActive, not recruitingNCT05570058Phase 2
- Atezolizumab for Idiopathic Pulmonary FibrosisActive, not recruitingNCT05515627Phase 1
- To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPFCompletedNCT05483907Phase 2
- Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy SubjectsCompletedNCT05473533Phase 1
- Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT05468502Phase 1
- Comparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary FibrosisStatus unknownNCT05449431Not applicable
- Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy VolunteersCompletedNCT05428150Phase 1
- A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary FibrosisStatus unknownNCT05424887Phase 2
- Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPFActive, not recruitingNCT05389215Phase 2
- Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary FibrosisStatus unknownNCT05387785Phase 1
- To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy VolunteersCompletedNCT05383131Phase 1
- RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Status unknownNCT05373914Phase 2
- Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary FibrosisCompletedNCT05366387Not applicable
- Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPFTerminatedNCT05359965Not applicable
- Effects of Home-based Inspiratory Muscle Training in Patients With IPFCompletedNCT05353556Not applicable
- A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary FibrosisWithdrawnNCT05349760Phase 2
- Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary FibrosisCompletedNCT05331729Phase 1
- LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)Active, not recruitingNCT05321420Phase 2
- Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control StudyActive, not recruitingNCT05313672
- Xenon MRI and Progressive ILDActive, not recruitingNCT05241275Phase 2
- Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF PatientsCompletedNCT05195918Phase 1
- Homecare Integral Support Program for IPF PatientsCompletedNCT05173571Not applicable
- A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsCompletedNCT05154240Phase 1
- Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy ParticipantsCompletedNCT05134727Phase 1
- Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）CompletedNCT05119972Phase 1/2
- Sleep Disorders in Idiopathic Pulmonary FibrosisCompletedNCT05113654
- Palliative Care Planner (PCplanner)CompletedNCT05095363Not applicable
- Phase ll Study of HEC585 in Patients With IPFActive, not recruitingNCT05060822Phase 2
- 23andMe IPF Research StudyCompletedNCT05028894
- A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015CompletedNCT05022771Phase 1
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPFTerminatedNCT05016817Phase 1
- Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ERCompletedNCT04996303Not applicable
- A Trial of SHR - 1906 in Healthy SubjectsCompletedNCT04986540Phase 1
- A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT04968574Phase 2
- A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy VolunteersCompletedNCT04931147Phase 1
- To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy VolunteersCompletedNCT04888728Phase 1
- To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy VolunteersCompletedNCT04888715Phase 1
- IPF mHealth Exercise StudyCompletedNCT04838275Not applicable
- Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung DiseaseCompletedNCT04803617
- Outcome of Idiopathic Pulmonary Fibrosis With PregnancyCompletedNCT04775277
- To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult VolunteersCompletedNCT04767815Phase 1
- A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal SubjectsCompletedNCT04720443Phase 1
- Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisCompletedNCT04708782Phase 3
- Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory DiseasesStatus unknownNCT04693975
- 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability StudyWithdrawnNCT04677426Phase 2
- Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)SuspendedNCT04643769Phase 1
- NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With NintedanibCompletedNCT04614441
- Saracatinib in the Treatment of Idiopathic Pulmonary FibrosisActive, not recruitingNCT04598919Phase 1/2
- TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary FibrosisTerminatedNCT04589260Phase 1
- FIBRotic Interstitial Lung Disease and Nocturnal OXygenCompletedNCT04586946
- Reliability and Validity of iOS in IPFCompletedNCT04572971
- Changes in iOS in IPFActive, not recruitingNCT04572958
- High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary FibrosisCompletedNCT04564664Not applicable
- Medication Adherence and Non-adherence in Adults With Rare DiseaseWithdrawnNCT04541875
- A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001CompletedNCT04540770Phase 1
- An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and ControlsCompletedNCT04529993Not applicable
- Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female SubjectsCompletedNCT04512170Phase 1
- Morphine for Dyspnea in Pulmonary FibrosisStatus unknownNCT04497831Phase 3
- Development of Airway Absorption Sampling MethodsWithdrawnNCT04494334
- Inspiratory Muscle Training in Patients With Interstitial Lung DiseaseCompletedNCT04481074Not applicable
- To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung DiseaseCompletedNCT04430491
- Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 InfectionStatus unknownNCT04326036Early Phase 1
- Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated CoughCompletedNCT04318704Phase 2
- Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant OutcomesCompletedNCT04316780
- Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary FibrosisCompletedNCT04312594Phase 2
- Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) TrialCompletedNCT04300920Phase 3
- A Study of Patients With Chronic DiseaseTerminatedNCT04263727
- Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary FibrosisActive, not recruitingNCT04262167Phase 1
- Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPDCompletedNCT04257630
- Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPFWithdrawnNCT04244825Phase 2
- Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult SubjectsCompletedNCT04233814Phase 1
- Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary FibrosisStatus unknownNCT04197791Not applicable
- Jin-shui Huan-xian Granule in the Treatment of IPFStatus unknownNCT04187690Not applicable
- Immunopathologic Profiles and Blood Biomarkers in Patients With IPFCompletedNCT04187079
- Cardiovascular Fibrosis in Idiopathic Pulmonary FibrosisCompletedNCT04177251
- Quality of Life in IPF - Patient and Physician PerceptionsCompletedNCT04148157
- A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327CompletedNCT04069143Phase 1
- Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis PatientsCompletedNCT04031690
- Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in SwedenStatus unknownNCT04019080
- Idiopathic Pulmonary Fibrosis and Serum BankCompletedNCT04016168
- Palliative Care and Quality of Life in Idiopathic Pulmonary FibrosisCompletedNCT03981406Not applicable
- A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy ParticipantsCompletedNCT03981094Phase 1
- Yoga in Patients With Fibrosing Interstitial Lung DiseasesCompletedNCT03979703Not applicable
- Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot StudyCompletedNCT03979430Not applicable
- A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary FibrosisTerminatedNCT03949530Phase 1
- ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis EvolutionCompletedNCT03944928
- Management of Progressive Disease in Idiopathic Pulmonary FibrosisCompletedNCT03939520Phase 4
- Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)CompletedNCT03901196
- Impulse Oscillometry for Prognostication in Idiopathic Pulmonary FibrosisCompletedNCT03898284
- Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary FibrosisCompletedNCT03890250Not applicable
- Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective StudyCompletedNCT03836417
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy SubjectsCompletedNCT03830125Phase 1
- Impact of Air Pollution on Chronic Respiratory DiseasesStatus unknownNCT03813810
- Nutritional Assessment in Idiopathic Pulmonary FibrosisCompletedNCT03770845
- Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and EfficacyCompletedNCT03761082
- BPF Genetics of ILD StudyCompletedNCT03747627
- PROOF-Registry New and Extended Belgium -LuxembourgCompletedNCT03732859
- Inhaled NAC in Treatment of IPFWithdrawnNCT03720483Phase 1/2